InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.250 0.03 (1.35%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$839 Application for quotation of securities - IDX 6 Sep 2023 10:31AM $2.970 $2.250 fallen by 24.24%
$839 Final Director's Interest Notice - John Atkin 1 Sep 2023 8:45AM $2.990 $2.250 fallen by 24.75%
$839 Initial Director's Interest Notice - Ingrid Player 30 Aug 2023 9:32AM $2.920 $2.250 fallen by 22.95%
$839 Change of Director's Interest Notice - Ian Kadish 29 Aug 2023 11:25AM $2.820 $2.250 fallen by 20.21%
$839 Notification of cessation of securities - IDX 29 Aug 2023 11:19AM $2.840 $2.250 fallen by 20.77%
$839 Appendix 4G and Corporate Governance Statement 28 Aug 2023 8:41AM $3.120 $2.250 fallen by 27.88%
$839 FY23 Investor Presentation 28 Aug 2023 8:40AM $3.120 $2.250 fallen by 27.88%
$839 FY23 Results Announcement 28 Aug 2023 8:39AM $3.120 $2.250 fallen by 27.88%
$839 Dividend/Distribution - IDX 28 Aug 2023 8:38AM $3.120 $2.250 fallen by 27.88%
$839 Appendix 4E and Annual Report to shareholders 28 Aug 2023 8:38AM $3.120 $2.250 fallen by 27.88%
$839 2023 Annual General Meeting 22 Aug 2023 8:40AM $3.170 $2.250 fallen by 29.02%
$839 Change in substantial holding 15 Aug 2023 8:05AM $3.180 $2.250 fallen by 29.25%
$839 Final Director's Interest Notice - Dr Nazar Bokani 10 Aug 2023 8:38AM $3.020 $2.250 fallen by 25.50%
$839 Board Changes 10 Aug 2023 8:35AM $3.020 $2.250 fallen by 25.50%
$839 Release from Escrow 7 Aug 2023 8:39AM $3.050 $2.250 fallen by 26.23%
$839 IDX FY23 Results Conference Call 26 Jul 2023 8:42AM $3.010 $2.250 fallen by 25.25%
$839 Change in substantial holding - IDX 3 Jul 2023 2:18PM $3.145 $2.250 fallen by 28.46%
$839 Release from Escrow 20 Jun 2023 9:25AM $3.180 $2.250 fallen by 29.25%
$839 Change in substantial holding 9 May 2023 5:01PM $3.250 $2.250 fallen by 30.77%
$839 Change of Director's Interest Notice - John Atkin 5 Apr 2023 1:07PM $2.940 $2.250 fallen by 23.47%
$839 Application for quotation of securities - IDX 4 Apr 2023 1:28PM $2.940 $2.250 fallen by 23.47%
$839 Update - Dividend/Distribution - IDX 20 Mar 2023 3:23PM $2.840 $2.250 fallen by 20.77%
$839 Change of Director's Interest Notice - Jacqueline Milne 24 Feb 2023 8:52AM $2.660 $2.250 fallen by 15.41%
$839 Half Year Results Investor Presentation 17 Feb 2023 8:19AM $3.140 $2.250 fallen by 28.34%
$839 Half Year Results Media Release 17 Feb 2023 8:17AM $3.140 $2.250 fallen by 28.34%

251 - 275 of 784 results

Page 11 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.